Jenifar Patel
Physician Assistant · Clermont, FLNPI 1780303420
Payments from drug & device makers
Across 104 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$546
- AstraZeneca$353
- Amgen$230
- GSK$154
- Bayer$111
- Lilly USA, LLC$80
- plus $421 from 11 others
What the payments were for
- Food & beverage$1,895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $546 |
| AstraZeneca | 19 | $353 |
| Amgen | 15 | $230 |
| GSK | 8 | $154 |
| Bayer | 5 | $111 |
| Lilly USA, LLC | 4 | $80 |
| Corcept Therapeutics | 3 | $59 |
| Boehringer Ingelheim | 3 | $53 |
| Medtronic | 2 | $52 |
| Radius Health, Inc. | 1 | $51 |
| Pfizer | 2 | $49 |
| Exact Sciences | 2 | $44 |
| AbbVie | 2 | $35 |
| Johnson & Johnson | 1 | $24 |
| Photonicare Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $17 |
How this compares
$1,895 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 54 | $62,446 |
| JardianceEmpagliflozin | 57 | $58,695 |
| OzempicSemaglutide | 41 | $55,274 |
| EliquisApixaban | 36 | $50,063 |
| RybelsusSemaglutide | 18 | $34,463 |
| XareltoRivaroxaban | 19 | $25,475 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $21,977 |
| TrulicityDulaglutide | 18 | $19,258 |
| TradjentaLinagliptin | 11 | $17,071 |
| JentaduetoLinagliptin/Metformin Hcl | 11 | $10,585 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $7,652 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $7,552 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $6,349 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $5,480 |
| Atorvastatin Calcium | 455 | $4,678 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $546 | $89,73759 claims |
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto | $53 | $86,35179 claims |
| AstraZenecaFarxiga | $353 | $62,44654 claims |
| PfizerEliquis | $49 | $50,06336 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $154 | $37,18150 claims |
| Johnson & JohnsonXarelto | $24 | $25,47519 claims |
| Lilly USA, LLCTrulicity | $80 | $19,25818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Clermont
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.